To further understand the role of the council and the affirmation of the GMAP by the secretary, the following explanations would rationalize them.
What is Advisory Council?
The Advisory Council for Price Regulation is a multi-sectoral organization with members consisting of representatives from the government and public sector, from the DOH-attached agencies, other government agencies, developmental partners, hospitals, private organizations medical societies, academe and the civil societies.
Who are the Members?
Complete list of the advisory members DPO No. 2009-5171
What are the functions of the Advisory Council for Price Regulation?
1. Gives advice to the Secretary of Health.
2. Assists the government in the implementation of guidelines as created.
3.
Promotes transparency in the drug price regulation system process
including the system for implementing the Maximum Drug Retail Price
Policy (MDRP) and the Government-Mediated Access Price (G-MAP).
The council has been an arm of the DOH in the implementation of
its guidelines. On July 08, 2009, Her Excellency-President Gloria
Macapagal-Arroyo directed pharmaceutical companies to voluntarily reduce
prices of their medicines. The council made recommendation to the
Secretary of Health by creating agreements through a series of
consultations with pharmaceutical companies in line with the
implementation of the voluntary reductions. On July 24, 2009 the ADVISORY
COUNCIL RESOLUTION 2009-001 ENTITLED IMPLEMENTING THE VOLUNTARY PRICE
REDUCTION FOR ATLEAST 16 MOLECULES OR (41 DRUG PREPARATIONS) was approved and signed by Secretary Francisco T. Duque III, MD. MSc.
What is the basis for the creation of the Advisory Council?
Drugs & Medicines Price Regulation Chapter 3. Section 18. “Drugs and Medicine Price Monitoring and Regulation Authority of the Secretary of the Department of Health”-To
implement the policies of this Act under this Chapter, the Secretary of
the Department of Health is hereby authorized to establish and initiate
a price monitoring and regulation system for drugs and medicines within
one hundred twenty (1200 days after the enactment of this Act. The
Secretary of the department of Health may also create such bodies,
consultative councils, from which
the advice may be sought in the implementation of a drug or medicine
price monitoring and regulation policy. Such bodies or consultative
councils created of the Secretary of the Department of Health shall
coordinate its effort together with other government agencies.
Therefore, the ADVISORY
COUNCIL PRICE REGULATION RESOLUTION 2009-001 is simply the GMAP. Please visit this site to view GMAP downloadables: http://rxistsource.blogspot.com/2013/06/mdrp-and-gmap.html#.Udgsraw65yQ
